161 related articles for article (PubMed ID: 34295225)
1. Corrigendum: Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH; Bordey A
Front Neuroanat; 2021; 15():715363. PubMed ID: 34295225
[TBL] [Abstract][Full Text] [Related]
2. Convergent and Divergent Mechanisms of Epileptogenesis in mTORopathies.
Nguyen LH; Bordey A
Front Neuroanat; 2021; 15():664695. PubMed ID: 33897381
[TBL] [Abstract][Full Text] [Related]
3. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
4. mTOR dysregulation and tuberous sclerosis-related epilepsy.
Curatolo P; Moavero R; van Scheppingen J; Aronica E
Expert Rev Neurother; 2018 Mar; 18(3):185-201. PubMed ID: 29338461
[TBL] [Abstract][Full Text] [Related]
5. mTOR signaling in epilepsy: insights from malformations of cortical development.
Crino PB
Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
[TBL] [Abstract][Full Text] [Related]
6. mTOR inhibitors as a new therapeutic option for epilepsy.
Curatolo P; Moavero R
Expert Rev Neurother; 2013 Jun; 13(6):627-38. PubMed ID: 23739000
[TBL] [Abstract][Full Text] [Related]
7. DEPDC5 as a potential therapeutic target for epilepsy.
Myers KA; Scheffer IE
Expert Opin Ther Targets; 2017 Jun; 21(6):591-600. PubMed ID: 28406046
[TBL] [Abstract][Full Text] [Related]
8. The mTOR pathway in treatment of epilepsy: a clinical update.
Griffith JL; Wong M
Future Neurol; 2018 May; 13(2):49-58. PubMed ID: 30505235
[TBL] [Abstract][Full Text] [Related]
9. The role of somatic mutational events in the pathogenesis of epilepsy.
Iffland PH; Crino PB
Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
Jeong A; Wong M
J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
[TBL] [Abstract][Full Text] [Related]
11. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
Zhang L; Huang T; Teaw S; Bordey A
Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
[TBL] [Abstract][Full Text] [Related]
12. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
[TBL] [Abstract][Full Text] [Related]
13. GATOR1 complex: the common genetic actor in focal epilepsies.
Baldassari S; Licchetta L; Tinuper P; Bisulli F; Pippucci T
J Med Genet; 2016 Aug; 53(8):503-10. PubMed ID: 27208208
[TBL] [Abstract][Full Text] [Related]
14. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.
Wong M
Epilepsia; 2008 Jan; 49(1):8-21. PubMed ID: 17727667
[TBL] [Abstract][Full Text] [Related]
16. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
18. Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis.
Zimmer TS; Broekaart DWM; Gruber VE; van Vliet EA; Mühlebner A; Aronica E
Front Neurol; 2020; 11():1028. PubMed ID: 33041976
[TBL] [Abstract][Full Text] [Related]
19. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy.
Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ
Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex with a single brain lesion on MRI mimicking focal cortical dysplasia.
Hirfanoglu T; Gupta A
Pediatr Neurol; 2010 May; 42(5):343-7. PubMed ID: 20399389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
